We are pleased to present the final agenda for the EFF 2020 Fall Summit.
The EFF Fall Summit will focus on the latest findings from sepofarsen and include interactive sessions related to the data, clinical and patient perspectives.
Here is the exciting program for EFF Fall Summit 2020:
Timetable – Wednesday 23 September 2020
Welcome to the webinar
Presented by: Daniel de Boer, CEO, ProQR Therapeutics
Time: 17:00 CET / 11:00 EST
Daniel de Boer, the CEO of ProQR will open the Fall EFF Summit giving a with an introduction on inclusiveness of the IRD community in our work and a short update on our programs.
Presented by: Aniz Girach, Chief Medical Officer, ProQR therapeutics
Time: 17:10 CET / 11:10 EST
Aniz Girach will give a short update on the latest findings of the sepofarsen program for LCA before starting the interactive sessions.
Live Q&A on LCA and sepofarsen
This session will start with a brief video with the highlights from the expert perspective call on LCA10 and sepofarsen.
Here you can find the complete version of this video (you need to register first). Immediately after, we will start with a Q&A session with Dr. Ian MacDonald and Dr. Aniz Girach. For 25 minutes they will be answering audience questions about LCA10 and sepofarsen data.
Panel discussion on patient’s perspective on clinical research.
To conclude the EFF Fall Summit, the audience has the chance to ask to our panelists questions focusing on our topic: patients perspective on clinical research.
We suggest watching the ProQR talks episode #2 as an introduction to the session.
Speaker: Daniel de Boer
Time: 18:30 CET / 12:30 EST
Time: 18:35 CET / 12:35 EST
To register and receive EFF updates, please subscribe:Skip back to main navigation